Bioinformatics driven in gene targeting platform for gold anticancer strategy delivery
Authors:
Open Access
- 18 October 2025
- journal article
- Published by Elsevier in Materials Today Bio
- Vol. 35, 102438
Abstract
No abstract availableKeywords
Funding Information
- Central South University (2025ZZTS0946)
- Natural Science Foundation of Hunan Province (2023JJ30720)
- Natural Science Foundation of Hunan Province (2025JJ40071)
- Natural Science Foundation of Hunan Province (2023JJ40800)
- Innovation-Driven Project of Central South University
- National Natural Science Foundation of China (81572900)
- National Natural Science Foundation of China (82303841)
This publication has 76 references indexed in Scilit:
- Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled releaseAdvanced Drug Delivery Reviews, 2024
- CD8+ T cell exhaustion and cancer immunotherapyCancer Letters, 2022
- Breast cancer: an up‐to‐date review and future perspectivesCancer Communications, 2022
- Disruption of ZNF334 promotes triple-negative breast carcinoma malignancy through the SFRP1/ Wnt/β-catenin signaling axisCellular and Molecular Life Sciences, 2022
- Tumor hypoxia-activated combinatorial nanomedicine triggers systemic antitumor immunity to effectively eradicate advanced breast cancerBiomaterials, 2021
- Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?Cancer Letters, 2021
- Single‐cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapyCancer Communications, 2020
- SDC1 promotes cisplatin resistance in hepatic carcinoma cells via PI3K-AKT pathwayHuman Cell, 2020
- Biosynthesized Gold Nanoclusters and Iron Complexes as Scaffolds for Multimodal Cancer BioimagingSmall, 2016
- Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivoAngiogenesis, 2013